Susquehanna International Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5458 |
|
|
2018
Q3 | – | Sell |
-88,499
| Closed | -$333K | – | 5363 |
|
|
2018
Q2 | $333K | Buy |
+88,499
| New | +$333K | ﹤0.01% | 2611 |
|
|
2018
Q1 | – | Sell |
-153,785
| Closed | -$715K | – | 5128 |
|
|
2017
Q4 | $715K | Sell |
153,785
-119,121
| -44% | -$554K | ﹤0.01% | 2078 |
|
|
2017
Q3 | $1.94M | Buy |
272,906
+37,198
| +16% | +$264K | ﹤0.01% | 1101 |
|
|
2017
Q2 | $1.7M | Buy |
235,708
+205,833
| +689% | +$1.49M | ﹤0.01% | 1338 |
|
|
2017
Q1 | $184K | Sell |
29,875
-468,981
| -94% | -$2.89M | ﹤0.01% | 2854 |
|
|
2016
Q4 | $2.92M | Buy |
498,856
+162,734
| +48% | +$954K | ﹤0.01% | 1075 |
|
|
2016
Q3 | $1.79M | Sell |
336,122
-31,745
| -9% | -$169K | ﹤0.01% | 1018 |
|
|
2016
Q2 | $2.44M | Sell |
367,867
-320,085
| -47% | -$2.12M | ﹤0.01% | 897 |
|
|
2016
Q1 | $3.21M | Buy |
687,952
+306,759
| +80% | +$1.43M | ﹤0.01% | 919 |
|
|
2015
Q4 | $1.93M | Buy |
381,193
+235,311
| +161% | +$1.19M | ﹤0.01% | 1595 |
|
|
2015
Q3 | $514K | Buy |
145,882
+116,030
| +389% | +$409K | ﹤0.01% | 3074 |
|
|
2015
Q2 | $298K | Sell |
29,852
-339,418
| -92% | -$3.39M | ﹤0.01% | 3779 |
|
|
2015
Q1 | $4.7M | Buy |
369,270
+227,722
| +161% | +$2.9M | ﹤0.01% | 896 |
|
|
2014
Q4 | $2M | Buy |
141,548
+44,717
| +46% | +$633K | ﹤0.01% | 1874 |
|
|
2014
Q3 | $1.33M | Sell |
96,831
-11,457
| -11% | -$157K | ﹤0.01% | 2070 |
|
|
2014
Q2 | $1.67M | Buy |
108,288
+79,378
| +275% | +$1.22M | ﹤0.01% | 1906 |
|
|
2014
Q1 | $493K | Sell |
28,910
-868,170
| -97% | -$14.8M | ﹤0.01% | 2632 |
|
|
2013
Q4 | $11.6M | Buy |
897,080
+561,593
| +167% | +$7.27M | 0.01% | 554 |
|
|
2013
Q3 | $3.39M | Buy |
335,487
+137,877
| +70% | +$1.39M | ﹤0.01% | 1103 |
|
|
2013
Q2 | $1.48M | Buy |
+197,610
| New | +$1.48M | ﹤0.01% | 1724 |
|